Skip to main content
NNMX logo

Nanomix Corporation (NNMX) Stock Analysis

DELISTED

What happened to Nanomix Corporation (NNMX) stock?

Nanomix Corporation (NNMX) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
Vol: 1| 52-wk range: $0.0001 – $0.0002
Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Nanomix Corporation (NNMX). Nanomix Corporation, formerly Boston Therapeutics, Inc., focuses on developing and commercializing therapeutic drugs and diagnostic tools for diabetes and inflammatory diseases.

Last analyzed: Mar 16, 2026
Nanomix Corporation, formerly Boston Therapeutics, Inc., focuses on developing and commercializing therapeutic drugs and diagnostic tools for diabetes and inflammatory diseases. Their pipeline includes treatments for post-meal blood glucose levels, necrosis prevention, and beta cell maturation, alongside diagnostic tools for cardiovascular risk assessment.

Nanomix Corporation (NNMX) Healthcare & Pipeline Overview

Employees30
Model self-rating on this text: 81% (not a measure of the evidence) Updated: Mar 16, 2026

NNMX OTC Market Information

NNMX trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

More about this archive record

Can I still buy NNMX shares?

No. NNMX stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for NNMX elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before NNMX stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Nanomix Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.